Cargando…
Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
Autores principales: | Vlahova, Filipa, Hawkins, Kate E., Ranzoni, Anna Maria, Hau, Kwan-Leong, Sagar, Rachel, De Coppi, Paolo, David, Anna L., Adjaye, James, Guillot, Pascale V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064593/ https://www.ncbi.nlm.nih.gov/pubmed/32157159 http://dx.doi.org/10.1038/s41598-020-61555-5 |
Ejemplares similares
-
Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
por: Vlahova, Filipa, et al.
Publicado: (2019) -
TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production
por: Hau, Kwan-Leong, et al.
Publicado: (2017) -
Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain
por: Hawkins, Kate E., et al.
Publicado: (2018) -
Neuroprotection of the hypoxic-ischemic mouse brain by human CD117(+)CD90(+)CD105(+) amniotic fluid stem cells
por: Corcelli, Michelangelo, et al.
Publicado: (2018) -
Counteracting bone fragility with human amniotic mesenchymal stem cells
por: Ranzoni, Anna M., et al.
Publicado: (2016)